Acumen Pharmaceuticals, Inc. (Nasdaq:ABOS)
Health Care/Life Sciences • Pharmaceuticals
CIK 1576885
Company
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Address
427 Park Street
Charlottesville, Virginia 22902
427 Park Street
Charlottesville, Virginia 22902
Employees
52
52
Stock Info
Close
$1.2300
$1.2300
Day Range
1.1800 - 1.2650
1.1800 - 1.2650
52 Week Range
1.1000 - 4.6000
1.1000 - 4.6000
Average volume
315.16K
315.16K
Short Interest
1.74M (02/14/25)
1.74M (02/14/25)
% of Float Shorted
3.97%
3.97%
Market Cap
$73.9M
$73.9M
Revenue
N/A
N/A
Net Income
-$52.37M
-$52.37M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Independent Director Kimberlee Cobleigh Drapkin |
Independent Director Sean Stalfort |
Independent Director Jeffrey L. Ives |
Independent Director Laura Stoppel |
Independent Director Nathan B. Fountain |
Independent Director Derrell D. Porter |
SEC filings
Date | Form | Event |
---|---|---|
12 Nov, 2024 | 8-K | |
12 Nov, 2024 | 10-Q | |
6 Nov, 2024 | 3 | |
6 Nov, 2024 | 4 | |
13 Aug, 2024 | 10-Q | |
13 Aug, 2024 | 8-K | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
5 Jun, 2024 | 8-K | |
14 May, 2024 | 8-K | |
14 May, 2024 | 10-Q | |
24 Apr, 2024 | EFFECT | |
22 Apr, 2024 | DEFA14A | |
22 Apr, 2024 | CORRESP | |
22 Apr, 2024 | ARS | |
22 Apr, 2024 | DEF 14A | |
2 Apr, 2024 | UPLOAD | |
27 Mar, 2024 | S-3 | |
27 Mar, 2024 | S-8 | |
26 Mar, 2024 | 10-K | |
26 Mar, 2024 | 8-K | |
19 Mar, 2024 | 8-K | |
14 Feb, 2024 | SC 13G/A | |
6 Feb, 2024 | SC 13G | |
1 Feb, 2024 | 3 | |
1 Feb, 2024 | 8-K | CEO Change |
1 Feb, 2024 | 4 | |
24 Jan, 2024 | SC 13G/A | |
18 Jan, 2024 | 144 | |
18 Jan, 2024 | 144 | |
18 Jan, 2024 | 144 | |
12 Jan, 2024 | 8-K | |
8 Jan, 2024 | 8-K | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Dec, 2023 | 8-K | |
13 Nov, 2023 | 10-Q | |
13 Nov, 2023 | 8-K | |
13 Nov, 2023 | 8-K | |
9 Nov, 2023 | 8-K | |
18 Aug, 2023 | 4 | |
17 Aug, 2023 | 144 | |
8 Aug, 2023 | 10-Q | |
8 Aug, 2023 | 8-K | |
25 Jul, 2023 | 4 | |
25 Jul, 2023 | SC 13D/A | |
20 Jul, 2023 | 8-K | |
20 Jul, 2023 | 424B5 | |
17 Jul, 2023 | 424B5 | |
17 Jul, 2023 | 8-K | |
17 Jul, 2023 | 8-K | |
13 Jun, 2023 | 4 | |
8 Jun, 2023 | 8-K | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
9 May, 2023 | 8-K | |
9 May, 2023 | 10-Q | |
28 Apr, 2023 | DEFA14A | |
27 Apr, 2023 | ARS | |
27 Apr, 2023 | 424B5 | |
27 Apr, 2023 | 8-K | |
27 Apr, 2023 | DEF 14A | |
14 Apr, 2023 | PRE 14A | |
28 Mar, 2023 | S-8 | |
27 Mar, 2023 | 8-K | |
27 Mar, 2023 | 10-K | |
15 Mar, 2023 | 8-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
1 Feb, 2023 | 8-K | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 3 | |
4 Jan, 2023 | 8-K | |
3 Jan, 2023 | 4 | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
24 Oct, 2022 | 8-K | |
7 Oct, 2022 | SC 13G/A | |
12 Sep, 2022 | 8-K | |
7 Sep, 2022 | 3 | |
7 Sep, 2022 | 4 | |
15 Aug, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
1 Aug, 2022 | 8-K | |
8 Jul, 2022 | EFFECT | |
6 Jul, 2022 | UPLOAD | |
6 Jul, 2022 | CORRESP | |
1 Jul, 2022 | S-3 | |
21 Jun, 2022 | 4 | |
21 Jun, 2022 | 8-K | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
16 May, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
27 Apr, 2022 | DEFA14A | |
27 Apr, 2022 | DEF 14A | |
4 Apr, 2022 | 3 | |
4 Apr, 2022 | 4 | |
29 Mar, 2022 | S-8 | |
28 Mar, 2022 | 10-K | |
28 Mar, 2022 | 8-K | |
16 Feb, 2022 | SC 13G | |
15 Feb, 2022 | SC 13G | |
14 Feb, 2022 | SC 13G | |
4 Feb, 2022 | SC 13G | |
27 Jan, 2022 | SC 13G | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
3 Jan, 2022 | 8-K | |
2 Dec, 2021 | 4 | |
15 Nov, 2021 | 10-Q | |
15 Nov, 2021 | 8-K | |
10 Nov, 2021 | 8-K | |
7 Oct, 2021 | 8-K | |
13 Sep, 2021 | SC 13D/A | |
31 Aug, 2021 | 8-K | |
16 Aug, 2021 | 10-Q | |
16 Aug, 2021 | 8-K | |
16 Jul, 2021 | SC 13D | |
13 Jul, 2021 | SC 13G | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 3/A | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
7 Jul, 2021 | 8-K | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | S-8 | |
2 Jul, 2021 | 424B4 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | SEC STAFF | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | EFFECT | |
30 Jun, 2021 | S-1MEF | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
29 Jun, 2021 | CERT | |
28 Jun, 2021 | CORRESP | |
28 Jun, 2021 | 8-A12B | |
28 Jun, 2021 | CORRESP | |
24 Jun, 2021 | S-1/A | |
24 Jun, 2021 | CORRESP | |
16 Jun, 2021 | CORRESP | |
14 Jun, 2021 | UPLOAD | |
9 Jun, 2021 | CORRESP | |
9 Jun, 2021 | S-1 | |
7 Jun, 2021 | SEC STAFF | |
3 Jun, 2021 | DRS/A | |
25 May, 2021 | UPLOAD | |
14 May, 2021 | DRS/A | |
14 May, 2021 | DRSLTR | |
10 May, 2021 | UPLOAD | |
12 Apr, 2021 | DRS |
Last update:2025-03-06 12:07:25.087695
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.